FDA
-
-
-
-
-
-
-
NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company's Thoracolumbar Interbody Portfolio
-
-
-
-
-
-
-
NuVasive Announces First Quarter 2021 Financial Results
-
-
-
-
-
-
-
NuVasive's (NUVA) Thoracolumbar Interbody Portfolio Receives First Clearance in the US for the Treatment of Sagittal Deformities
-
-
-
-
-
-
-
Randomized Controlled Trial Results Published in 'Spine' Demonstrate Efficacy of NuVasive Attrax® Putty in Posterolateral Lumbar Fusion
-
-
-
-
-
-
-
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting
-
-
-
-
-
-
-
NuVasive Grows Cervical Spinal Interbody Portfolio With PEEK Corpectomy Implant
-
-
-
-
-
-
-
NuVasive Receives Expanded FDA 510(k) Clearance For TLX Interbody System Used In TLIF Procedures
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

